SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 88 filers reported holding SYNAGEVA BIOPHARMA CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $15,797,000 | -29.0% | 161,970 | -32.4% | 0.41% | -28.5% |
Q4 2014 | $22,238,000 | +46.2% | 239,660 | +8.4% | 0.57% | +37.2% |
Q3 2014 | $15,212,000 | -27.7% | 221,169 | +10.1% | 0.42% | -30.6% |
Q2 2014 | $21,045,000 | +127.4% | 200,813 | +80.0% | 0.60% | +99.7% |
Q1 2014 | $9,256,000 | -38.5% | 111,556 | -52.0% | 0.30% | -35.7% |
Q4 2013 | $15,046,000 | +134.2% | 232,475 | +129.4% | 0.47% | +121.8% |
Q3 2013 | $6,425,000 | +886.9% | 101,350 | +553.9% | 0.21% | +20.6% |
Q2 2013 | $651,000 | – | 15,500 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 10,660,432 | $989,182,000 | 10.10% |
BB BIOTECH AG | 1,130,476 | $104,897,000 | 3.40% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 80,000 | $7,423,000 | 3.31% |
Opus Point Partners Management, LLC | 20,002 | $1,856,000 | 1.84% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,847,094 | $356,972,000 | 1.77% |
SECTORAL ASSET MANAGEMENT INC | 363,884 | $33,765,000 | 1.52% |
Cormorant Asset Management, LP | 100,000 | $9,279,000 | 1.43% |
Tekla Capital Management LLC | 223,020 | $20,694,000 | 0.97% |
Lamond Capital Partners LLC | 15,390 | $1,428,000 | 0.94% |
Squarepoint Ops LLC | 6,700 | $622,000 | 0.60% |